CASE DISCUSSION
Acute tropical illness: Diagnosis and Management Challenges
Presented India by Dr. Manjunath ThimmappaViews
21,299
Credit Points
Learning Hours
CPD Points
CME Points
Courses Completed
Case Description
In the case of an acute ill patient with a tropical illness, prompt and accurate diagnosis is crucial to ensure appropriate treatment and prevent further complications. The patient's travel history and symptoms should be carefully evaluated, and laboratory tests may be necessary to confirm the...
Case Summary
- The presentation focuses on tropical illnesses prevalent in India, highlighting the changing paradigms due to globalization and rainfall patterns. The mortality, incidence, and morbidity associated with these illnesses vary each decade, posing challenges in diagnosis and management. Intensive care unit (ICU) settings face specific difficulties in handling tropical illnesses like leptospirosis, scrub typhus, and typhoid fever due to atypical presentations and delays in diagnosis.
Speaker Profile
Dr. Manjunath Thimmappa
MD Anaesthesiology, FNB Critical Care, EDIC(Dublin), PGDMLE – NLSIU, (MBA – HHCM) Consultant, Critical care medicine @Manipal Hospital, Whitefield, BENGALURU ,INDIADr. Manjunath Thimmappa is a Consultant in Critical Care Medicine at Manipal Hospital Whitefield with extensive expertise in intensive care and emergency management.
He holds qualifications including MD in Anaesthesiology, FNB Critical Care, EDIC (Dublin), PGDMLE from NLSIU, and MBA in Healthcare & Hospital Management.
His clinical interests include advanced critical care, organ support therapies, sepsis management, and ICU protocols.
He is experienced in managing complex critically ill patients using evidence-based and multidisciplinary care approaches.
Through his academic and clinical contributions, he continues to support advancements in critical care medicine and healthcare leadership.
Disclosures
Assimilate requires every individual in a position to control educational content to disclose all financial relationships with ineligible companies that have occurred within the past 24 months. Ineligible companies are organizations whose primary business is producing, marketing, selling, re-selling, or distributing healthcare products used by or on patients. All relevant financial relationships for anyone with the ability to control the content of this educational activity have been reviewed and mitigated. Others involved in the planning of this activity have no relevant financial relationships.